TWO SIGMA INVESTMENTS, LP - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$704,333
-71.4%
120,605
-67.2%
0.00%
-75.0%
Q3 2022$2,465,000
+145.5%
367,952
+54.3%
0.01%
+166.7%
Q2 2022$1,004,000
+2410.0%
238,476
+1887.3%
0.00%
Q1 2022$40,000
-86.0%
12,000
-86.8%
0.00%
-100.0%
Q4 2021$286,000
+140.3%
90,900
+149.6%
0.00%
Q3 2021$119,000
-37.4%
36,424
-19.1%
0.00%
Q2 2021$190,000
-76.6%
45,000
-72.3%
0.00%
-100.0%
Q1 2021$811,000
+123.4%
162,597
+465.5%
0.00%
+100.0%
Q4 2020$363,000
+14.9%
28,753
-10.7%
0.00%0.0%
Q3 2020$316,000
-28.0%
32,192
-27.1%
0.00%
-50.0%
Q2 2020$439,000
-8.7%
44,131
-18.8%
0.00%
-50.0%
Q1 2020$481,000
-31.1%
54,359
-28.1%
0.00%
+100.0%
Q4 2019$698,000
-3.2%
75,654
-38.3%
0.00%0.0%
Q3 2019$721,000
-42.6%
122,559
+17.0%
0.00%
-50.0%
Q2 2019$1,257,000
+208.8%
104,756
+210.4%
0.00%
+300.0%
Q1 2019$407,000
-21.9%
33,750
-18.8%
0.00%
-50.0%
Q4 2018$521,000
-50.5%
41,539
-41.4%
0.00%
-33.3%
Q3 2018$1,052,000
+46.9%
70,906
+66.6%
0.00%
+50.0%
Q2 2018$716,000
-81.8%
42,550
-72.0%
0.00%
-84.6%
Q4 2017$3,929,000
+371.1%
151,875
+210.6%
0.01%
+333.3%
Q1 2017$834,000
+94.9%
48,900
+56.0%
0.00%
+50.0%
Q1 2016$428,000
-59.7%
31,340
-55.3%
0.00%
-60.0%
Q1 2015$1,062,000
+76.4%
70,096
+55.2%
0.01%
+66.7%
Q4 2014$602,00045,1630.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
L1 Capital Pty Ltd 968,198$9,634,0003.29%
INGALLS & SNYDER LLC 1,382,048$13,751,0000.79%
SPHERA FUNDS MANAGEMENT LTD. 700,710$6,972,0000.66%
Alambic Investment Management, L.P. 17,900$178,0000.45%
RA Capital Management 1,858,474$18,492,0000.36%
Perceptive Advisors 2,150,641$21,398,0000.35%
Eversept Partners, LP 232,983$2,318,1810.32%
GSA CAPITAL PARTNERS LLP 17,351$173,0000.10%
Alyeska Investment Group, L.P. 502,783$5,003,0000.08%
KENNEDY CAPITAL MANAGEMENT LLC 263,958$2,626,0000.08%
View complete list of CONCERT PHARMACEUTICALS INC shareholders